Literature DB >> 17169379

Nucleotide metabolizing ecto-enzymes in Walker 256 tumor cells: molecular identification, kinetic characterization and biochemical properties.

Andréia Buffon1, Vanessa B Ribeiro, Márcia R Wink, Emerson A Casali, João J F Sarkis.   

Abstract

In this study we describe the molecular identification, kinetic characterization and biochemical properties of an E-NTPDase and an 5'-nucleotidase in Walker 256 cells. For the ATP, ADP and AMP hydrolysis there were optimum pH in the range 6.5-8.0, and absolute requirement for divalent cations (Mg(2+)>Ca(2+)). A significant inhibition of ATP and ADP hydrolysis was observed in the presence of high concentrations of sodium azide and 0.5 mM of Gadolinium chloride. These activities were insensitive to ATPase, adenylate kinase and alkaline phosphatase classical inhibitors. The K(m) values were 464.2+/-86.6 microM (mean+/-SEM, n=4), 137.0+/-31 microM (mean+/-SEM, n=5) and 44.8+/-10.2 microM (mean+/-SEM, n=4), and V(max) values were 655.0+/-94.6 (mean+/-SEM, n=4), 236.3+/-27.2 (mean+/-SEM, n=5) and 177.6+/-13.8 (mean+/-SEM, n=5) nmol of inorganic phosphate min(-1) mg of protein(-1) for ATP, ADP and AMP, respectively. Using RT-PCR analysis we identified the mRNA of two members of the ecto-nucleoside triphosphate diphosphohydrolase family (NTPDase 2 and 5) and a 5'-nucleotidase. The presence of NTPDases and 5'-nucleotidase enzymes in Walker 256 tumor cells may be important to regulate the ratio adenine nucleotides/adenine nucleoside extracellularly, therefore motivating tumor growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169379     DOI: 10.1016/j.lfs.2006.11.024

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

2.  Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases).

Authors:  Younis Baqi; Stefanie Weyler; Jamshed Iqbal; Herbert Zimmermann; Christa E Müller
Journal:  Purinergic Signal       Date:  2008-06-05       Impact factor: 3.765

3.  Bilateral downregulation of Nav1.8 in dorsal root ganglia of rats with bone cancer pain induced by inoculation with Walker 256 breast tumor cells.

Authors:  Xue-Rong Miao; Xiao-Fei Gao; Jing-Xiang Wu; Zhi-Jie Lu; Zhang-Xiang Huang; Xiao-Qing Li; Cheng He; Wei-Feng Yu
Journal:  BMC Cancer       Date:  2010-05-20       Impact factor: 4.430

4.  Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5'-carboxamide.

Authors:  Andreas Brunschweiger; Jamshed Iqbal; Frank Umbach; Anja B Scheiff; Mercedes N Munkonda; Jean Sévigny; Aileen F Knowles; Christa E Müller
Journal:  J Med Chem       Date:  2008-07-17       Impact factor: 7.446

5.  Extracellular ATP is Differentially Metabolized on Papillary Thyroid Carcinoma Cells Surface in Comparison to Normal Cells.

Authors:  Ana Paula Santin Bertoni; Rafael Paschoal de Campos; Marisa Tsao; Elizandra Braganhol; Tania Weber Furlanetto; Márcia Rosângela Wink
Journal:  Cancer Microenviron       Date:  2018-02-17

6.  Imatinib mesylate affects extracellular ATP catabolism and expression of NTPDases in a chronic myeloid leukemia cell line.

Authors:  Julia Biz Willig; Débora Renz Barreto Vianna; Aline Beckenkamp; Liziane Raquel Beckenkamp; Jean Sévigny; Márcia Rosângela Wink; Andréia Buffon; Diogo André Pilger
Journal:  Purinergic Signal       Date:  2020-01-18       Impact factor: 3.765

7.  Characterisation of Walker 256 breast carcinoma cells from two tumour cell banks as assessed using two models of secondary brain tumours.

Authors:  Kate M Lewis; Elizabeth Harford-Wright; Robert Vink; Mounir N Ghabriel
Journal:  Cancer Cell Int       Date:  2013-02-01       Impact factor: 5.722

8.  Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.

Authors:  Aline Beckenkamp; Júlia Biz Willig; Danielle Bertodo Santana; Jéssica Nascimento; Juliano Domiraci Paccez; Luiz Fernando Zerbini; Alessandra Nejar Bruno; Diogo André Pilger; Márcia Rosângela Wink; Andréia Buffon
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.